Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 3/20 | 1.00 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.70 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.70 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.70 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.70 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.70 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.70 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.70 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.70 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.70 |
| ▸ | CYP1A1 | P04798 | 5/20 | 0.62 |
| ▸ | CYP1B1 | Q16678 | 5/20 | 0.62 |
| ▸ | P4HB | P07237 | 1/20 | 0.62 |
| ▸ | HSD11B1 | P28845 | 2/20 | 0.61 |
| ▸ | MAOB | P27338 | 6/20 | 0.59 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.57 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.57 |
| ▸ | F3 | P13726 | 1/20 | 0.57 |
| ▸ | TYR | P14679 | 1/20 | 0.57 |
| ▸ | MAOA | P21397 | 3/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8781291 | 1.00 | CYP1A2 (1.00) | CYP1A2HDAC3ADAM17HDAC1HDAC2 | |
| SCHEMBL8781296 | 1.00 | CYP1A2 (1.00) | CYP1A2HDAC3ADAM17HDAC1HDAC2 | |
| SCHEMBL11971119 | 0.93 | CYP1A2 (0.86) | CYP1A2HDAC3ADAM17HDAC1HDAC2 | |
| SCHEMBL28739875 | 0.93 | CYP1A2 (0.86) | CYP1A2HDAC3ADAM17HDAC1HDAC2 | |
| SCHEMBL11971113 | 0.93 | CYP1A2 (0.86) | CYP1A2HDAC3ADAM17HDAC1HDAC2 | |
| SCHEMBL10467116 | 0.91 | CYP1A2 (0.83) | CYP1A2HDAC3ADAM17HDAC1HDAC2 | |
| SCHEMBL11999777 | 0.91 | CYP1A2 (0.83) | CYP1A2HDAC3ADAM17HDAC1HDAC2 | |
| SCHEMBL10467114 | 0.91 | CYP1A2 (0.83) | CYP1A2HDAC3ADAM17HDAC1HDAC2 | |
| SCHEMBL8858005 | 0.89 | CYP1A2 (0.79) | CYP1A2HDAC3ADAM17HDAC1HDAC2 | |
| SCHEMBL8858000 | 0.89 | CYP1A2 (0.79) | CYP1A2HDAC3ADAM17HDAC1HDAC2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240390294-A1 | INHIBITION OF COVID-19 VIRUS BY MULTIPLE-COMPONENT FORMULATIONS | ANKH LIFE SCIENCES LIMITED (IE) | 2024-11-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240390294-A1 | INHIBITION OF COVID-19 VIRUS BY MULTIPLE-COMPONENT FORMULATIONS | MAVS, IDO2, IDO1 | CYP1A2 392/4885HDAC3 565/4885ADAM17 1220/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.